MDRNA (MRNA) Soars After FDA Approval For Generic Calcitonin-Salmon Nasal Spray
Tweet Send to a Friend
Shares of MDRNA, Inc. (Nasdaq: MRNA) have doubled in pre-open trading today after the company announced it has obtained ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


